ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hemoperfusion Production Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-32X6236
Home | Market Reports | Health| Medical Devices & Equipment
Global Hemoperfusion Production Market Insights and Forecast to 2028
BUY CHAPTERS

Global Hemoperfusion Production Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-32X6236
Report
May 2025
Pages:137
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Jafron Biomedical
Baxter-Gambro
Biosun Medical
Toray Medical
Asahi Kasei
Kaneka
Zibo Kangbei
Aier
Cytosorbents

Hemoperfusion Production Market Size

In 2024, the global market size of Hemoperfusion Production was estimated to be worth US$ 763 million and is forecast to reach approximately US$ 2051 million by 2031 with a CAGR of 15.4% during the forecast period 2025-2031.

Hemoperfusion Production Market

Hemoperfusion Production Market

Hemoperfusion is a treatment technique in which large volumes of the patient"s blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient"s body.
Global Hemoperfusion Production key players include Baxter (Gambro), Jafron Biomedical, Biosun Medical, Asahi-Kasei, etc. Global top four manufacturers hold a share over 80%.
China is the largest market, with a share over 65%, followed by Europe, and Japan, both have a share about 30 percent.
In terms of product, Resin Adsorption is the largest segment, with a share over 65%. And in terms of application, the largest application is Hepatic Encephalopathy, followed by Certain Autoimmune Diseases, Overdose, Specific Intoxications, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hemoperfusion Production, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoperfusion Production.
The Hemoperfusion Production market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hemoperfusion Production market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemoperfusion Production manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Hemoperfusion Production Market Report

Report Metric Details
Report Name Hemoperfusion Production Market
Forecasted market size in 2031 approximately US$ 2051 million
CAGR 15.4%
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Overdose
  • Specific Intoxications
  • Certain Autoimmune Diseases
  • Hepatic Encephalopathy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Jafron Biomedical, Baxter (Gambro), Biosun Medical, Toray Medical, Asahi-Kasei, Kaneka, Zibo Kangbei, Aier, Cytosorbents
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Hemoperfusion Production in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Hemoperfusion Production manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hemoperfusion Production sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Hemoperfusion Production Market size in 2031?

Ans: The Hemoperfusion Production Market size in 2031 will be approximately US$ 2051 million.

What is the market share of major companies in Hemoperfusion Production Market?

Ans: Global top four manufacturers hold a share over 80%.

What is the Hemoperfusion Production Market share by type?

Ans: In terms of product, Resin Adsorption is the largest segment, with a share over 65%.

Who are the main players in the Hemoperfusion Production Market report?

Ans: The main players in the Hemoperfusion Production Market are Jafron Biomedical, Baxter (Gambro), Biosun Medical, Toray Medical, Asahi-Kasei, Kaneka, Zibo Kangbei, Aier, Cytosorbents

What are the Application segmentation covered in the Hemoperfusion Production Market report?

Ans: The Applications covered in the Hemoperfusion Production Market report are Overdose, Specific Intoxications, Certain Autoimmune Diseases, Hepatic Encephalopathy, Others

What are the Type segmentation covered in the Hemoperfusion Production Market report?

Ans: The Types covered in the Hemoperfusion Production Market report are Resin Adsorption, Activated Carbon Adsorption, Others

Recommended Reports

Blood Purification Devices

Hemostasis & Hemostatic

Blood Separation Tools

Market trends :

Topic Trends
Global the global hemoperfusion production market is experiencing rapid growth driven by increasing adoption in hepatic encephalopathy treatment and expanding applications in critical care across apac and emea regions.
Type Resin Adsorption - resin adsorption remains the dominant technology in hemoperfusion due to superior efficacy and broad clinical acceptance.
Activated Carbon Adsorption - activated carbon adsorption sees steady demand for specific intoxication cases but faces competition from advanced resin-based solutions.
Application Overdose - increasing incidence of drug overdose cases drives adoption of hemoperfusion as an adjunctive detoxification therapy.
Specific Intoxications - growing awareness of hemoperfusion's effectiveness in treating specific intoxications supports market expansion.
Certain Autoimmune Diseases - clinical trials and expanded indications for autoimmune diseases boost hemoperfusion utilization in immunomodulatory therapies.
Hepatic Encephalopathy - hepatic encephalopathy remains the largest application segment, with rising prevalence fueling demand for hemoperfusion treatments.
Company Jafron Biomedical - jafron biomedical maintains a leading position in the hemoperfusion market through continuous product innovation and strong presence in the chinese market.
Baxter (Gambro) - baxter (gambro) leverages its global distribution network to expand access to hemoperfusion products, particularly in europe and north america.
Biosun Medical - biosun medical focuses on expanding its product portfolio to address a broader range of intoxication and autoimmune disease applications.
Toray Medical - toray medical invests in r&d to enhance adsorption efficiency and broaden clinical indications for its hemoperfusion devices.
Asahi-Kasei - asahi-kasei strengthens its market share by targeting emerging markets in apac and introducing advanced hemoperfusion technologies.
Kaneka - kaneka emphasizes product differentiation through proprietary resin technologies to capture niche segments in the hemoperfusion market.
Zibo Kangbei - zibo kangbei expands manufacturing capacity to meet growing domestic demand for hemoperfusion devices in china.
Aier - aier increases its focus on strategic partnerships to enhance distribution and clinical adoption of hemoperfusion products.
Cytosorbents - cytosorbents accelerates commercialization efforts in europe and north america, targeting critical care and intoxication treatment markets.
Region North America - north america sees increased adoption of hemoperfusion driven by regulatory approvals and integration into critical care protocols.
EMEA - emea region experiences growth in hemoperfusion usage due to expanding clinical guidelines and reimbursement support.
APAC - apac leads global market growth, propelled by high demand in china and rising healthcare investments.
LATAM - latam market for hemoperfusion is emerging, with gradual adoption in major urban healthcare centers.
1 Study Coverage
1.1 Hemoperfusion Production Product Introduction
1.2 Market by Type
1.2.1 Global Hemoperfusion Production Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Resin Adsorption
1.2.3 Activated Carbon Adsorption
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hemoperfusion Production Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Overdose
1.3.3 Specific Intoxications
1.3.4 Certain Autoimmune Diseases
1.3.5 Hepatic Encephalopathy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hemoperfusion Production Market Size Estimates and Forecasts
2.1.1 Global Hemoperfusion Production Revenue 2020-2031
2.1.2 Global Hemoperfusion Production Sales 2020-2031
2.2 Hemoperfusion Production Market Size by Region: 2024 Versus 2031
2.3 Hemoperfusion Production Sales by Region (2020-2031)
2.3.1 Global Hemoperfusion Production Sales by Region: 2020-2025
2.3.2 Global Hemoperfusion Production Sales Forecast by Region (2026-2031)
2.3.3 Global Hemoperfusion Production Sales Market Share by Region (2020-2031)
2.4 Hemoperfusion Production Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Hemoperfusion Production Revenue by Region: 2020-2025
2.4.2 Global Hemoperfusion Production Revenue Forecast by Region (2026-2031)
2.4.3 Global Hemoperfusion Production Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Hemoperfusion Production Sales by Type (2020-2031)
3.1.1.1 Global Hemoperfusion Production Sales Volume by Type (2020-2031)
3.1.1.2 Global Hemoperfusion Production Sales Market Share by Type (2020-2031)
3.1.2 Global Hemoperfusion Production Revenue by Type (2020-2031)
3.1.2.1 Global Hemoperfusion Production Revenue by Type (2020-2031)
3.1.2.2 Global Hemoperfusion Production Revenue Market Share by Type (2020-2031)
3.1.3 Hemoperfusion Production Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Hemoperfusion Production Sales by Application (2020-2031)
3.2.1.1 Global Hemoperfusion Production Sales Volume by Application (2020-2031)
3.2.1.2 Global Hemoperfusion Production Sales Market Share by Application (2020-2031)
3.2.2 Global Hemoperfusion Production Revenue by Application (2020-2031)
3.2.2.1 Global Hemoperfusion Production Revenue by Application (2020-2031)
3.2.2.2 Global Hemoperfusion Production Revenue Market Share by Application (2020-2031)
3.2.3 Hemoperfusion Production Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Resin Adsorption of Hemoperfusion Production Revenue Market Share by Application
3.3.2 Activated Carbon Adsorption of Hemoperfusion Production Revenue Market Share by Application
3.3.3 Others of Hemoperfusion Production Revenue Market Share by Application
4 Global Hemoperfusion Production by Manufacturers
4.1 Global Top Hemoperfusion Production Manufacturers by Sales (2020-2025)
4.1.1 Global Hemoperfusion Production Sales by Manufacturer (2020-2025)
4.1.2 Global Hemoperfusion Production Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Hemoperfusion Production Manufacturers by Revenue (2020-2025)
4.2.1 Global Hemoperfusion Production Revenue by Manufacturer (2020-2025)
4.2.2 Global Hemoperfusion Production Revenue Share by Manufacturer (2020-2025)
4.3 Global Hemoperfusion Production Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Hemoperfusion Production Manufacturers Covered: Ranking by Revenue
4.4.2 Global Hemoperfusion Production Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Hemoperfusion Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Hemoperfusion Production Manufacturing Base Distribution, Product Type
4.5.1 Hemoperfusion Production Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Hemoperfusion Production Market
4.5.3 Manufacturers Hemoperfusion Production Product Type and Application
4.5.4 Resin Adsorption Market Sales of Hemoperfusion Production by Manufacturer
4.5.5 Activated Carbon Adsorption Market Sales of Hemoperfusion Production by Manufacturer
4.5.6 Others Market Sales of Hemoperfusion Production by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Jafron Biomedical
5.1.1 Jafron Biomedical Company Information
5.1.2 Jafron Biomedical Description, Business Overview
5.1.3 Jafron Biomedical Hemoperfusion Production Products Offered
5.1.4 Jafron Biomedical Hemoperfusion Production Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Jafron Biomedical Hemoperfusion Production Sales by Product in 2024
5.1.6 Jafron Biomedical Hemoperfusion Production Sales by Application in 2024
5.1.7 Jafron Biomedical Hemoperfusion Production Sales by Geographic Area in 2024
5.1.8 Jafron Biomedical Recent Developments
5.2 Baxter (Gambro)
5.2.1 Baxter (Gambro) Company Information
5.2.2 Baxter (Gambro) Description, Business Overview
5.2.3 Baxter (Gambro) Hemoperfusion Production Products Offered
5.2.4 Baxter (Gambro) Hemoperfusion Production Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Baxter (Gambro) Hemoperfusion Production Sales by Product in 2024
5.2.6 Baxter (Gambro) Hemoperfusion Production Sales by Application in 2024
5.2.7 Baxter (Gambro) Hemoperfusion Production Sales by Geographic Area in 2024
5.2.8 Baxter (Gambro) Recent Developments
5.3 Biosun Medical
5.3.1 Biosun Medical Company Information
5.3.2 Biosun Medical Description, Business Overview
5.3.3 Biosun Medical Hemoperfusion Production Products Offered
5.3.4 Biosun Medical Hemoperfusion Production Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Biosun Medical Hemoperfusion Production Sales by Product in 2024
5.3.6 Biosun Medical Hemoperfusion Production Sales by Application in 2024
5.3.7 Biosun Medical Hemoperfusion Production Sales by Geographic Area in 2024
5.3.8 Biosun Medical Recent Developments
5.4 Toray Medical
5.4.1 Toray Medical Company Information
5.4.2 Toray Medical Description, Business Overview
5.4.3 Toray Medical Hemoperfusion Production Products Offered
5.4.4 Toray Medical Hemoperfusion Production Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Toray Medical Hemoperfusion Production Sales by Product in 2024
5.4.6 Toray Medical Hemoperfusion Production Sales by Application in 2024
5.4.7 Toray Medical Hemoperfusion Production Sales by Geographic Area in 2024
5.4.8 Toray Medical Recent Developments
5.5 Asahi-Kasei
5.5.1 Asahi-Kasei Company Information
5.5.2 Asahi-Kasei Description, Business Overview
5.5.3 Asahi-Kasei Hemoperfusion Production Products Offered
5.5.4 Asahi-Kasei Hemoperfusion Production Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Asahi-Kasei Hemoperfusion Production Sales by Product in 2024
5.5.6 Asahi-Kasei Hemoperfusion Production Sales by Application in 2024
5.5.7 Asahi-Kasei Hemoperfusion Production Sales by Geographic Area in 2024
5.5.8 Asahi-Kasei Recent Developments
5.6 Kaneka
5.6.1 Kaneka Company Information
5.6.2 Kaneka Description, Business Overview
5.6.3 Kaneka Hemoperfusion Production Products Offered
5.6.4 Kaneka Hemoperfusion Production Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Kaneka Hemoperfusion Production Sales by Product in 2024
5.6.6 Kaneka Hemoperfusion Production Sales by Application in 2024
5.6.7 Kaneka Hemoperfusion Production Sales by Geographic Area in 2024
5.6.8 Kaneka Recent Developments
5.7 Zibo Kangbei
5.7.1 Zibo Kangbei Company Information
5.7.2 Zibo Kangbei Description, Business Overview
5.7.3 Zibo Kangbei Hemoperfusion Production Products Offered
5.7.4 Zibo Kangbei Hemoperfusion Production Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Zibo Kangbei Hemoperfusion Production Sales by Product in 2024
5.7.6 Zibo Kangbei Hemoperfusion Production Sales by Application in 2024
5.7.7 Zibo Kangbei Hemoperfusion Production Sales by Geographic Area in 2024
5.7.8 Zibo Kangbei Recent Developments
5.8 Aier
5.8.1 Aier Company Information
5.8.2 Aier Description, Business Overview
5.8.3 Aier Hemoperfusion Production Products Offered
5.8.4 Aier Hemoperfusion Production Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Aier Hemoperfusion Production Sales by Product in 2024
5.8.6 Aier Hemoperfusion Production Sales by Application in 2024
5.8.7 Aier Hemoperfusion Production Sales by Geographic Area in 2024
5.8.8 Aier Recent Developments
5.9 Cytosorbents
5.9.1 Cytosorbents Company Information
5.9.2 Cytosorbents Description, Business Overview
5.9.3 Cytosorbents Hemoperfusion Production Products Offered
5.9.4 Cytosorbents Hemoperfusion Production Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Cytosorbents Hemoperfusion Production Sales by Product in 2024
5.9.6 Cytosorbents Hemoperfusion Production Sales by Application in 2024
5.9.7 Cytosorbents Hemoperfusion Production Sales by Geographic Area in 2024
5.9.8 Cytosorbents Recent Developments
6 North America
6.1 North America Hemoperfusion Production Market Size YoY Growth 2020-2031
6.2 North America Hemoperfusion Production Market Facts & Figures by Country
6.2.1 North America Hemoperfusion Production Sales by Country (2020-2031)
6.2.2 North America Hemoperfusion Production Revenue by Country (2020-2031)
6.3 North America Hemoperfusion Production Sales by Type (2020-2025)
6.4 North America Hemoperfusion Production Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Hemoperfusion Production Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Hemoperfusion Production Market Facts & Figures by Region
7.2.1 Asia-Pacific Hemoperfusion Production Sales by Region (2020-2031)
7.2.2 Asia-Pacific Hemoperfusion Production Revenue by Region (2020-2031)
7.3 Asia-Pacific Hemoperfusion Production Sales by Type (2020-2025)
7.4 Asia-Pacific Hemoperfusion Production Sales by Application (2020-2025)
8 Europe
8.1 Europe Hemoperfusion Production Market Size YoY Growth 2020-2031
8.2 Europe Hemoperfusion Production Market Facts & Figures by Country
8.2.1 Europe Hemoperfusion Production Sales by Country (2020-2031)
8.2.2 Europe Hemoperfusion Production Revenue by Country (2020-2031)
8.3 Europe Hemoperfusion Production Sales by Type (2020-2025)
8.4 Europe Hemoperfusion Production Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Hemoperfusion Production Market Size YoY Growth 2020-2031
9.2 Latin America Hemoperfusion Production Market Facts & Figures by Country
9.2.1 Latin America Hemoperfusion Production Sales by Country (2020-2031)
9.2.2 Latin America Hemoperfusion Production Revenue by Country (2020-2031)
9.3 Latin America Hemoperfusion Production Sales by Type (2020-2025)
9.4 Latin America Hemoperfusion Production Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Hemoperfusion Production Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Hemoperfusion Production Market Facts & Figures by Country
10.2.1 Middle East and Africa Hemoperfusion Production Sales by Country (2020-2031)
10.2.2 Middle East and Africa Hemoperfusion Production Revenue by Country (2020-2031)
10.3 Middle East and Africa Hemoperfusion Production Sales by Type (2020-2025)
10.4 Middle East and Africa Hemoperfusion Production Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Hemoperfusion Production Supply Chain Analysis
11.2 Hemoperfusion Production Key Raw Materials and Upstream Suppliers
11.3 Hemoperfusion Production Clients Analysis
11.4 Hemoperfusion Production Sales Channel and Sales Model Analysis
11.4.1 Hemoperfusion Production Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Hemoperfusion Production Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Hemoperfusion Production Distributors
12 Hemoperfusion Production Market Dynamics
12.1 Hemoperfusion Production Industry Trends
12.2 Hemoperfusion Production Market Drivers
12.3 Hemoperfusion Production Market Challenges
12.4 Hemoperfusion Production Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Jafron Biomedical
Baxter-Gambro
Biosun Medical
Toray Medical
Asahi Kasei
Kaneka
Zibo Kangbei
Aier
Cytosorbents
List of Tables
 Table 1. Global Hemoperfusion Production Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Hemoperfusion Production Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Hemoperfusion Production Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Hemoperfusion Production Sales by Region (2020-2025) & (K Units)
 Table 5. Global Hemoperfusion Production Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Hemoperfusion Production Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Hemoperfusion Production Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Hemoperfusion Production Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Hemoperfusion Production Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Hemoperfusion Production Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Hemoperfusion Production Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Hemoperfusion Production Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Hemoperfusion Production Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Hemoperfusion Production Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Hemoperfusion Production Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Hemoperfusion Production Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Hemoperfusion Production Sales Share by Manufacturer (2020-2025)
 Table 18. Hemoperfusion Production Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Hemoperfusion Production Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Hemoperfusion Production Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Hemoperfusion Production Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Hemoperfusion Production Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Hemoperfusion Production by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoperfusion Production as of 2024)
 Table 24. Hemoperfusion Production Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Hemoperfusion Production Market
 Table 26. Manufacturers Hemoperfusion Production Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Jafron Biomedical Company Information
 Table 29. Jafron Biomedical Description and Business Overview
 Table 30. Jafron Biomedical Hemoperfusion Production Product
 Table 31. Jafron Biomedical Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Jafron Biomedical Sales Proportion of Hemoperfusion Production by Product in 2024
 Table 33. Jafron Biomedical Sales Proportion of Hemoperfusion Production by Application in 2024
 Table 34. Jafron Biomedical Sales Proportion of Hemoperfusion Production by Geographic Area in 2024
 Table 35. Jafron Biomedical Recent Developments
 Table 36. Baxter (Gambro) Company Information
 Table 37. Baxter (Gambro) Description and Business Overview
 Table 38. Baxter (Gambro) Hemoperfusion Production Product
 Table 39. Baxter (Gambro) Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Baxter (Gambro) Sales Proportion of Hemoperfusion Production by Product in 2024
 Table 41. Baxter (Gambro) Sales Proportion of Hemoperfusion Production by Application in 2024
 Table 42. Baxter (Gambro) Sales Proportion of Hemoperfusion Production by Geographic Area in 2024
 Table 43. Baxter (Gambro) Recent Developments
 Table 44. Biosun Medical Company Information
 Table 45. Biosun Medical Description and Business Overview
 Table 46. Biosun Medical Hemoperfusion Production Product
 Table 47. Biosun Medical Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Biosun Medical Sales Proportion of Hemoperfusion Production by Product in 2024
 Table 49. Biosun Medical Sales Proportion of Hemoperfusion Production by Application in 2024
 Table 50. Biosun Medical Sales Proportion of Hemoperfusion Production by Geographic Area in 2024
 Table 51. Biosun Medical Recent Developments
 Table 52. Toray Medical Company Information
 Table 53. Toray Medical Description and Business Overview
 Table 54. Toray Medical Hemoperfusion Production Product
 Table 55. Toray Medical Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Toray Medical Sales Proportion of Hemoperfusion Production by Product in 2024
 Table 57. Toray Medical Sales Proportion of Hemoperfusion Production by Application in 2024
 Table 58. Toray Medical Sales Proportion of Hemoperfusion Production by Geographic Area in 2024
 Table 59. Toray Medical Recent Developments
 Table 60. Asahi-Kasei Company Information
 Table 61. Asahi-Kasei Description and Business Overview
 Table 62. Asahi-Kasei Hemoperfusion Production Product
 Table 63. Asahi-Kasei Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Asahi-Kasei Sales Proportion of Hemoperfusion Production by Product in 2024
 Table 65. Asahi-Kasei Sales Proportion of Hemoperfusion Production by Application in 2024
 Table 66. Asahi-Kasei Sales Proportion of Hemoperfusion Production by Geographic Area in 2024
 Table 67. Asahi-Kasei Recent Developments
 Table 68. Kaneka Company Information
 Table 69. Kaneka Description and Business Overview
 Table 70. Kaneka Hemoperfusion Production Product
 Table 71. Kaneka Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Kaneka Sales Proportion of Hemoperfusion Production by Product in 2024
 Table 73. Kaneka Sales Proportion of Hemoperfusion Production by Application in 2024
 Table 74. Kaneka Sales Proportion of Hemoperfusion Production by Geographic Area in 2024
 Table 75. Kaneka Recent Developments
 Table 76. Zibo Kangbei Company Information
 Table 77. Zibo Kangbei Description and Business Overview
 Table 78. Zibo Kangbei Hemoperfusion Production Product
 Table 79. Zibo Kangbei Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Zibo Kangbei Sales Proportion of Hemoperfusion Production by Product in 2024
 Table 81. Zibo Kangbei Sales Proportion of Hemoperfusion Production by Application in 2024
 Table 82. Zibo Kangbei Sales Proportion of Hemoperfusion Production by Geographic Area in 2024
 Table 83. Zibo Kangbei Recent Developments
 Table 84. Aier Company Information
 Table 85. Aier Description and Business Overview
 Table 86. Aier Hemoperfusion Production Product
 Table 87. Aier Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Aier Sales Proportion of Hemoperfusion Production by Product in 2024
 Table 89. Aier Sales Proportion of Hemoperfusion Production by Application in 2024
 Table 90. Aier Sales Proportion of Hemoperfusion Production by Geographic Area in 2024
 Table 91. Aier Recent Developments
 Table 92. Cytosorbents Company Information
 Table 93. Cytosorbents Description and Business Overview
 Table 94. Cytosorbents Hemoperfusion Production Product
 Table 95. Cytosorbents Hemoperfusion Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. Cytosorbents Sales Proportion of Hemoperfusion Production by Product in 2024
 Table 97. Cytosorbents Sales Proportion of Hemoperfusion Production by Application in 2024
 Table 98. Cytosorbents Sales Proportion of Hemoperfusion Production by Geographic Area in 2024
 Table 99. Cytosorbents Recent Developments
 Table 100. North America Hemoperfusion Production Sales by Country (2020-2025) & (K Units)
 Table 101. North America Hemoperfusion Production Sales by Country (2026-2031) & (K Units)
 Table 102. North America Hemoperfusion Production Revenue by Country (2020-2025) & (US$ Million)
 Table 103. North America Hemoperfusion Production Revenue by Country (2026-2031) & (US$ Million)
 Table 104. North America Hemoperfusion Production Sales by Type (2020-2025) & (K Units)
 Table 105. North America Hemoperfusion Production Sales by Application (2020-2025) & (K Units)
 Table 106. Asia-Pacific Hemoperfusion Production Sales by Region (2020-2025) & (K Units)
 Table 107. Asia-Pacific Hemoperfusion Production Sales by Region (2026-2031) & (K Units)
 Table 108. Asia-Pacific Hemoperfusion Production Revenue by Region (2020-2025) & (US$ Million)
 Table 109. Asia-Pacific Hemoperfusion Production Revenue by Region (2026-2031) & (US$ Million)
 Table 110. Asia-Pacific Hemoperfusion Production Sales by Type (2020-2025) & (K Units)
 Table 111. Asia-Pacific Hemoperfusion Production Sales by Application (2020-2025) & (K Units)
 Table 112. Europe Hemoperfusion Production Sales by Country (2020-2025) & (K Units)
 Table 113. Europe Hemoperfusion Production Sales by Country (2026-2031) & (K Units)
 Table 114. Europe Hemoperfusion Production Revenue by Country (2020-2025) & (US$ Million)
 Table 115. Europe Hemoperfusion Production Revenue by Country (2026-2031) & (US$ Million)
 Table 116. Europe Hemoperfusion Production Sales by Type (2020-2025) & (K Units)
 Table 117. Europe Hemoperfusion Production Sales by Application (2020-2025) & (K Units)
 Table 118. Latin America Hemoperfusion Production Sales by Country (2020-2025) & (K Units)
 Table 119. Latin America Hemoperfusion Production Sales by Country (2026-2031) & (K Units)
 Table 120. Latin America Hemoperfusion Production Revenue by Country (2020-2025) & (US$ Million)
 Table 121. Latin America Hemoperfusion Production Revenue by Country (2026-2031) & (US$ Million)
 Table 122. Latin America Hemoperfusion Production Sales by Type (2020-2025) & (K Units)
 Table 123. Latin America Hemoperfusion Production Sales by Application (2020-2025) & (K Units)
 Table 124. Middle East and Africa Hemoperfusion Production Sales by Country (2020-2025) & (K Units)
 Table 125. Middle East and Africa Hemoperfusion Production Sales by Country (2026-2031) & (K Units)
 Table 126. Middle East and Africa Hemoperfusion Production Revenue by Country (2020-2025) & (US$ Million)
 Table 127. Middle East and Africa Hemoperfusion Production Revenue by Country (2026-2031) & (US$ Million)
 Table 128. Middle East and Africa Hemoperfusion Production Sales by Type (2020-2025) & (K Units)
 Table 129. Middle East and Africa Hemoperfusion Production Sales by Application (2020-2025) & (K Units)
 Table 130. Hemoperfusion Production Key Raw Materials, Industry Status and Trend
 Table 131. Hemoperfusion Production Key Raw Materials and Upstream Suppliers
 Table 132. Hemoperfusion Production Clients Status and Trend
 Table 133. Hemoperfusion Production Typical Clients
 Table 134. Hemoperfusion Production Distributors
 Table 135. Hemoperfusion Production Market Trends
 Table 136. Hemoperfusion Production Market Drivers
 Table 137. Hemoperfusion Production Market Challenges
 Table 138. Hemoperfusion Production Market Restraints
 Table 139. Research Programs/Design for This Report
 Table 140. Key Data Information from Secondary Sources
 Table 141. Key Data Information from Primary Sources
 Table 142. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Hemoperfusion Production Product Picture
 Figure 2. Global Hemoperfusion Production Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Hemoperfusion Production Sales Market Share by Type in 2024 & 2031
 Figure 4. Resin Adsorption Product Picture
 Figure 5. Activated Carbon Adsorption Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Hemoperfusion Production Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Hemoperfusion Production Sales Market Share by Application in 2024 & 2031
 Figure 9. Overdose
 Figure 10. Specific Intoxications
 Figure 11. Certain Autoimmune Diseases
 Figure 12. Hepatic Encephalopathy
 Figure 13. Others
 Figure 14. Hemoperfusion Production Report Years Considered
 Figure 15. Global Hemoperfusion Production Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Hemoperfusion Production Market Size 2020-2031 (US$ Million)
 Figure 17. Global Hemoperfusion Production Sales 2020-2031 (K Units)
 Figure 18. Global Hemoperfusion Production Sales Market Share Forecast by Region (2020-2031)
 Figure 19. Global Hemoperfusion Production Revenue Market Share by Region (2020-2031)
 Figure 20. Global Hemoperfusion Production Sales Market Share Forecast by Type (2020-2031)
 Figure 21. Global Hemoperfusion Production Revenue Market Share Forecast by Type (2020-2031)
 Figure 22. Hemoperfusion Production Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 23. Global Hemoperfusion Production Sales Market Share Forecast by Application (2020-2031)
 Figure 24. Global Hemoperfusion Production Revenue Market Share Forecast by Application (2020-2031)
 Figure 25. Hemoperfusion Production Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 26. Resin Adsorption of Hemoperfusion Production Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Activated Carbon Adsorption of Hemoperfusion Production Revenue Market Share by Application, 2024 VS 2031
 Figure 28. Others of Hemoperfusion Production Revenue Market Share by Application, 2024 VS 2031
 Figure 29. Global Hemoperfusion Production Sales Share by Manufacturer in 2024
 Figure 30. Hemoperfusion Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 31. Resin Adsorption Market Sales Proportion by Manufacturer in 2024
 Figure 32. Activated Carbon Adsorption Market Sales Proportion by Manufacturer in 2024
 Figure 33. Others Market Sales Proportion by Manufacturer in 2024
 Figure 34. North America Hemoperfusion Production Revenue 2020-2031 (US$ Million)
 Figure 35. North America Hemoperfusion Production Sales Market Share by Type (2020-2025)
 Figure 36. North America Hemoperfusion Production Sales Market Share by Application (2020-2025)
 Figure 37. Asia-Pacific Hemoperfusion Production Revenue 2020-2031 (US$ Million)
 Figure 38. Asia-Pacific Hemoperfusion Production Sales Market Share by Region (2020-2031)
 Figure 39. Asia-Pacific Hemoperfusion Production Revenue Market Share by Region (2020-2031)
 Figure 40. Asia-Pacific Hemoperfusion Production Sales Market Share by Type (2020-2025)
 Figure 41. Asia-Pacific Hemoperfusion Production Sales Market Share by Application (2020-2025)
 Figure 42. Europe Hemoperfusion Production Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Europe Hemoperfusion Production Sales Market Share by Country (2020-2031)
 Figure 44. Europe Hemoperfusion Production Revenue Market Share by Country (2020-2031)
 Figure 45. Europe Hemoperfusion Production Sales Market Share by Type (2020-2025)
 Figure 46. Europe Hemoperfusion Production Sales Market Share by Application (2020-2025)
 Figure 47. Latin America Hemoperfusion Production Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 48. Latin America Hemoperfusion Production Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Hemoperfusion Production Revenue Market Share by Country (2020-2025)
 Figure 50. Latin America Hemoperfusion Production Sales Market Share by Type (2020-2025)
 Figure 51. Latin America Hemoperfusion Production Sales Market Share by Application (2020-2025)
 Figure 52. Middle East and Africa Hemoperfusion Production Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 53. Middle East and Africa Hemoperfusion Production Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Hemoperfusion Production Revenue Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Hemoperfusion Production Sales Market Share by Type (2020-2025)
 Figure 56. Middle East and Africa Hemoperfusion Production Sales Market Share by Application (2020-2025)
 Figure 57. Hemoperfusion Production Supply Chain (Upstream and Downstream Market)
 Figure 58. Global Production Market Share of Hemoperfusion Production Raw Materials by Region in 2024
 Figure 59. Hemoperfusion Production Distribution Channels
 Figure 60. Global Hemoperfusion Production Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 61. Global Hemoperfusion Production Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Hemoperfusion Market Insights Forecast to 2030
Global Disposable Hemoperfusion Market Research Report 2025
Global Blood Perfusion Machines Market Research Report 2025
Global Blood Perfusion Device Market Research Report 2025
Global Disposable Hemoperfusion Device Market Research Report 2025
Global Critical Care Adsorption Solutions Market Research Report 2024
Hemodialyzer and Hemoperfusion Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Adsorbent Market Research Report 2025
Global Hemoperfusion Apparatus Market Research Report 2024
Hemoperfusion Machines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adsorption Blood Purifier Market Research Report 2024
Global Hemoperfusion Medical Device Market Research Report 2024
Extracorporeal Blood Purification Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemoperfusion Filter Market Research Report 2024
Global Blood Purification Equipment Market Insights Forecast to 2030
Medical Disposable Hemoperfusion Cartridge Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blood Purification System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blood Purification Machine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Kidney Blood Purification Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blood Purification Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions